DELAPLEX.NS,0P0001SALQ,21600

DELAPLEX · General/Diversified · NSE

₹269

Current Market Price

Near Fair Value

Fair Value (DCF)

₹204

Discount to FV

-24.1%

Valuation engine: DCF

Updated just now

DCF Sensitivity →

YieldIQ Score

43/100

Piotroski F-Score

6/9

Economic Moat

Moderate

Confidence

48%

ROE

Debt/Equity

0.00

WACC

11.1%

Market Cap

₹245.15 Cr

Quality & Valuation

Neutral model outputs — no recommendations.

ROCE

Return on capital employed

EV / EBITDA

Enterprise multiple

Debt / EBITDA

Leverage vs earnings

Interest Coverage

EBIT covers interest

Current Ratio

Short-term liquidity

Asset Turnover

0.74×

Revenue per ₹ of assets

Revenue CAGR (3Y)

8.5%

3-year revenue growth

Revenue CAGR (5Y)

5-year revenue growth

DCF Scenario Analysis

vs CMP ₹269.1

Bear case

Discount -114.8%

Base case

Discount -31.8%

Bull case

Discount -6.2%

Ratio Trends

Historical ratio trends for DELAPLEX are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.

Historical Financials

Historical financials for DELAPLEX are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.

Peer Comparison

Peers not yet ranked for DELAPLEX. Comparable companies and side-by-side valuation will appear here once the peer set is established.

Dividend History

No dividend events recorded for DELAPLEX in the last 10 years.

AI Analysis Summary

Model-generated description of metrics. Not investment advice. DELAPLEX.NS,0P0001SALQ,21600 (DELAPLEX.NS) trades at 269.10 vs a model fair value of 204.21, a gap of -24.1%. Piotroski F-score: 6/9. Moa...

Read full AI analysis →

Run Full Interactive Analysis

Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.

Analyse DELAPLEXNow →

Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.